Gastrointestinal Symptoms in Marfan Syndrome and Hypermobile Ehlers-Danlos Syndrome
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Objective. Marfan syndrome (MS) is a multisystem disorder caused by a mutation in FBN1 gene. It shares some phenotypic features with hypermobile Ehlers-Danlos syndrome (EDS) such as joint hypermobility. EDS is a group of inherited heterogenous multisystem disorders characterized by skin hyperextensibility, atrophic scarring, joint hypermobility, and generalized tissue fragility. Hypermobile EDS (hEDS) is thought to be the most common type. Recent studies have suggested an association between connective tissue hypermobility and functional gastrointestinal disorders (FGDs). The aim of this study is to determine the prevalence of gastrointestinal symptoms in patients with Marfan syndrome and hypermobile EDS. Method. Patients with a diagnosis of either MS or hEDS attending cardiology or rheumatology outpatients at our hospital were asked to complete SF36 RAND and Rome IV Diagnostic questionnaires. Questionnaires were also completed by patients who are members of Marfan Association UK. The same questionnaires were also completed by age- and gender-matched controls attending fracture clinic without existing diagnoses of MS or hEDS. Results. Data were collected from 45 MS patients (12 males and 33 females, age range 19–41 years, mean 28 years) and 45 hEDS patients (6 males and 39 females, age range 18–32 years, mean 24 years). None had a previous organic gastrointestinal diagnosis. The control group was matched for age and sex (18 males and 72 females, age range 18–45, mean 29 years). Both MS and hEDS groups showed a higher prevalence of abdominal symptoms compared to the control group; however, the hEDS group not only showed a higher prevalence but more frequent and severe symptoms meeting Rome IV criteria for diagnosis of FGIDs. Nearly half of the hEDS patients met the criteria for more than one FGID. The hEDS group also scored lower on quality of life (QOL) scores in comparison to either of the other groups with a mean score of 48.6 as compared to 54.2 in the Marfan group and 78.6 in the control group. Conclusion. FGIDs are reported in both Marfan syndrome and hypermobile Ehlers-Danlos syndrome but appear to be more common and severe in hEDS. These patients score lower on quality of life scores as well despite hypermobility being a common feature of both conditions. Further work is needed to understand the impact of connective tissue disorders on gastrointestinal symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“functional dysphagia (34.2%, 95% CI 25.7–43.8)”
From Meta-Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders (2026) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“functional constipation (19.3%, 95% CI 10.3–33.1)”
From Meta-Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders (2026) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“functional diarrhoea (5%, 95% CI 1.6–14.8)”
From Meta-Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders (2026) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“functional bloating (7.8%, 95% CI 2.8–19.9)”
From Meta-Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders (2026) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“functional heartburn (29.9%, 95% CI 23.9–36.8)”
From Meta-Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders (2026) · cites this paper as [27]
Experimental — accuracy not yet measured
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The revised Ghent nosology for the Marfan syndrome: Table 1
Loeys, B. L., Dietz, H. C., Braverman, A. C., Callewaert, B. L., De Backer, J., Devereux, R. B., Hilhorst-Hofstee, Y., Jondeau, G., Faivre, L., Milewicz, D. M., et al. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.072785 · Cited by 2,229 · cited 1×
“The revised Ghent criteria for diagnosing Marfan syndrome were published in 2010 [18, 19].”
The 2017 international classification of the Ehlers–Danlos syndromes
Malfait, F., Francomano, C., Byers, P., Belmont, J., Berglund, B., Black, J., Bloom, L., Bowen, J. M., Brady, A. F., Burrows, N. P., et al. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31552 · Cited by 1,936 · cited 1×
“The current classification of EDS is based on the 2017 international classification of Ehlers-Danlos syndrome which includes the traditional six types as well as other rarer types [34].”
MethodJudge, D. P., & Dietz, H. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67789-6 · Cited by 1,210 · cited 1×
“It shares some phenotypic features with hypermobile Ehlers-Danlos syndrome (EDS) such as joint hypermobility [2].”
BackgroundTinkle, B., Castori, M., Berglund, B., Cohen, H., Grahame, R., Kazkaz, H., & Levy, H. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31538 · Cited by 499 · cited 1×
“Hypermobile EDS (hEDS) is thought to be the most common type [4].”
BackgroundLocation on Chromosome 15 of the Gene Defect Causing Marfan Syndrome
Kainulainen, K., Pulkkinen, L., Savolainen, A., Kaitila, I., & Peltonen, L. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010043231402 · Cited by 376 · cited 1×
“The defect itself has been isolated to the FBN1 gene on chromosome 15, which codes for the connective tissue protein fibrillin [11].”
BackgroundOcular Manifestations in the Marfan Syndrome and Homocystinuria
Cross, H. E., & Jensen, A. D. (1973) · American Journal of Ophthalmology · doi:10.1016/0002-9394(73)91149-5 · Cited by 258
Ehlers-Danlos syndromes and Marfan syndrome
Callewaert, B., Malfait, F., Loeys, B., & De Paepe, A. (2008) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2007.12.005 · Cited by 257 · cited 1×
“EDS is a group of inherited heterogenous multisystem disorders characterized by skin hyperextensibility, atrophic scarring, joint hypermobility, and generalized tissue fragility [3].”
BackgroundMarfan Syndrome—Diagnosis and Management
Ammash, N. M., Sundt, T. M., & Connolly, H. M. (2008) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2007.10.001 · Cited by 203 · cited 1×
“Aortic root dilatation and dissection [12] are perhaps the most serious manifestations whereas skeletal deformities [13] including thoracolumbar scoliosis, thoracic lordosis, and pectus excavatum can lead to pulmonary problems [14] if left untreated.”
BackgroundEhlers Danlos syndrome and gastrointestinal manifestations: a 20‐year experience at Mayo Clinic
Nelson, A. D., Mouchli, M. A., Valentin, N., Deyle, D., Pichurin, P., Acosta, A., & Camilleri, M. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12665 · Cited by 182 · cited 2×
“Structural abnormalities have been reported in up to 20% of individuals and functional gastrointestinal symptoms in up to 75% [10, 36].”
BackgroundPulmonary disease in patients with Marfan syndrome.
Wood, J. R., Bellamy, D., Child, A. H., & Citron, K. M. (1984) · Thorax · doi:10.1136/thx.39.10.780 · Cited by 180 · cited 1×
“Aortic root dilatation and dissection [12] are perhaps the most serious manifestations whereas skeletal deformities [13] including thoracolumbar scoliosis, thoracic lordosis, and pectus excavatum can lead to pulmonary problems [14] if left untreated.”
BackgroundSelf-citation
Research works printed but not linked: 1
- Dietz H. Adam M. P. Ardinger H. H. Pagon R. A. Inayet N. Marfan syndrome. 2001 Apr 18 [Updated 2017 Oct 12] Gene Reviews® [Internet] 1993-2018 Seattle, WA, USA University of Washington Available from: https://www.ncbi.nlm.nih.gov/books/NBK1335/
Cited by
Lam, C. Y., Palsson, O. S., Whitehead, W. E., Sperber, A. D., Tornblom, H., Simren, M., & Aziz, I. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.02.034 · Cited by 71
“Indeed, studies report that FGIDs can be present in over 90% of subjects with HSD/hEDS, although such findings are limited to case-series, cohort studies, and a few small secondarycare case-control studies.(2-12) Moreover, the association between HSD/hEDS and FGIDs may be confounded by alternate factors, such as somat…”
BackgroundResultThwaites, P. A., Gibson, P. R., & Burgell, R. E. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15927 · Cited by 59
The biopsychosocial impact of hypermobility spectrum disorders in adults: a scoping review
Clark, N., Johnson, M., Rangan, A., Kottam, L., & Swainston, K. (2023) · Rheumatology International · doi:10.1007/s00296-023-05298-2 · Cited by 36
Pain Symptomatology and Management in Pediatric Ehlers–Danlos Syndrome: A Review
Feldman, E. C. H., Hivick, D. P., Slepian, P. M., Tran, S. T., Chopra, P., & Greenley, R. N. (2020) · Children · doi:10.3390/children7090146 · Cited by 24
“Despite abdominal pain being well reported in adults with EDS, no research which identifies interventions to alleviate such uncomfortable symptoms outside a concurrent diagnosis of FGID could be identified, likely due to the unclear etiology of such pain in the context of EDS.”
BackgroundInfluentialFunctional somatic syndromes and joint hypermobility: A systematic review and meta-analysis
Chen, G. H., Olver, J. S., & Kanaan, R. (2021) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2021.110556 · Cited by 16
Schubart, J. R., Schaefer, É., Knight, D. R. T., Mills, S. E., & Francomano, C. A. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1365712 · Cited by 15
Gastrointestinal symptoms in acromegaly: A case control study
Inayet, N., Hayat, J., Bano, G., & Poullis, A. P. (2020) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v11.i2.17 · Cited by 13
Self-citationChoudhary, A., Fikree, A., Ruffle, J. K., Takahashi, K., Palsson, O. S., Aziz, I., & Aziz, Q. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14957 · Cited by 11
“…FD present as the two most common DGBI in hEDS/HSD corroborate with published literature which shows a prevalence of 23%–48% of IBS in hEDS/HSD 4,21,22 and inversely, a 41.9% prevalence of hEDS/HSD in IBS 23 ; A 28%–68% prevalence of FD in hEDS/HSD, 21,24 and inversely a 55% prevalence of…”
InfluentialOleksandrivna, C. M., Berezovskyi, A. M., Shamrai, V. A., & Postolovskyi, L. I. (2019) · Reports of Vinnytsia National Medical University · doi:10.31393/reports-vnmedical-2019-23(3)-29 · Cited by 7
Sweerts, K. W. E., Mujagic, Z., Keszthelyi, D., & Conchillo, J. M. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18471 · Cited by 6
Oleksandrivna, C. M., Vitaliivna, S. O., Petrivna, S. L., Borisivna, Y. O., Prystupiuk, M., Prystupiuk, L., & Naumova, M. (2021) · Archives of Pharmacy Practice · doi:10.51847/ymuzdzle7y · Cited by 6
de Koning, L. E., Warnink‐Kavelaars, J., van Rossum, M. A. J., Bosman, D. K., Menke, L. A., Malfait, F., de Boer, R., Oosterlaan, J., Engelbert, R., Rombaut, L., et al. (2023) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63204 · Cited by 5
“Nonspecific somatic symptoms, such as headache, nausea, palpitations, constipation, diarrhea, dizziness, faintness and others have been regularly reported in adults with hEDS, MFS and LDS (De Wandele et al., 2013; Inayet et al., 2018; Wang et al., 2021).”
BackgroundTosas, M. R. (2025) · The Journal of Medicine and Philosophy A Forum for Bioethics and Philosophy of Medicine · doi:10.1093/jmp/jhaf004 · Cited by 4
Umar, T. P., Sayad, R., Mokresh, M. E., Chakhide, M., Mahjoub, R., Saad, H., Griffiths, M. D., Khair, K., & Mohammed, L. (2023) · Mediterranean Journal of Clinical Psychology · doi:10.13129/2282-1619/mjcp-3665 · Cited by 4
Maconi, G., Pini, A., Pasqualone, E., Ardizzone, S., & Bassotti, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103141 · Cited by 4
“However, whereas joint hypermobility syndrome and EDS display a high prevalence of functional GI disorders, in MFS, the prevalence of GI disorders is still disputed [13,14,24,25].”
BackgroundChoudhary, A., Makwana, K., Nee, J., & Aziz, Q. (2025) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003315 · Cited by 3
Steiner, L., Bodensteiner, A., & Johnson, N. (2023) · Journal of Orthopedic Research and Therapy · doi:10.29011/2575-8241.001313 · Cited by 2
Kulin, D., Holtmann, G., Fairlie, T., Staller, K., Nurko, S., Keefer, L., Drossman, D. A., Jones, M. P., Aziz, Q., & Shah, A. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70856 · Cited by 1
Garcia‐Fischer, I., Abber, S. R., Silvernale, C. J., Rodis, J., Murray, H. B., & Staller, K. D. (2025) · International Journal of Eating Disorders · doi:10.1002/eat.24576 · Cited by 1
Cecal volvulus in Marfan Syndrome
Yip, S. Y., Rashid, A., & Ward, S. (2024) · Journal of Surgical Case Reports · doi:10.1093/jscr/rjac543 · Cited by 1
Oberschmidt, R. A. (2023) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Hemorragia digestiva alta en un paciente con enfermedad de Marfan
Ruiz-Rodríguez, A. J., Robles, A. G., & Fernández, A. B. (2021) · Medicina Clínica · doi:10.1016/j.medcli.2021.04.017
Upper gastrointestinal bleeding in a patient with Marfan’s disease
Ruiz-Rodríguez, A. J., Robles, A. G., & Fernández, A. B. (2022) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2021.04.023
Paiba, N., & Harris, M. D. (2023) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2023.102231
Structural Gastrointestinal and Urogenital Dysfunction and hEDS/HSD
DePace, N. L., Soloway, S., Yayac, M. F., & Colombo, J. (2025) · Springer eBooks · doi:10.1007/978-3-031-88769-7_12
Oleksandrivna, C. M., Vitaliivna, S. O., Petrivna, S. L., Borisivna, Y. O., Prystupiuk, M., Prystupiuk, L., & Naumova, M. (2021) · International Journal of Social and Psychological Aspects of Healthcare · doi:10.51847/ujef04ggvk
Brunet‐Garcia, L. (2024) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Çocuklarda Kabızlık: Bütüncül Yaklaşım
Tangul, S. U., Şenaylı, A., Taşdan, K., Kulice, E. C., Tural, E., Külice, G. K., Domur, E., Tural, Y., Koçak, M. G., & Şenaylı, Y. (2026) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.4311
Mugica, A. B. (2026) · Saber Estratégico Internacional · doi:10.70577/s.e.v4i4.146
Metadata
- Authors
- Inayet, N., Hayat, J. O., Kaul, A., Tome, M., Child, A., & Poullis, A.
- Affiliations
- St George's Hospital (GB)
- Corresponding author
- Inayet, N.
- Venue
- Gastroenterology Research and Practice
- Publisher
- Wiley
- Published
- 2018-07-29
- Volume
- 2018
- Pages
- 1-8
- ISSN
- 1687-6121 (ISSN-L)
- 1687-630X
- PMC
- PMC6087563
- OpenAlex
- W2884843956
- Cited by
- 23
- References
- 37
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 4 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 1
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Gastroenterology Research and Practice (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- St. George’s Hospital
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
- Keywords
- Marfan syndrome, hypermobile Ehlers-Danlos syndrome, functional gastrointestinal disorders, gastrointestinal symptoms, connective tissue diseases, joint hypermobility, quality of life, Rome IV criteria, fibrillin-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.